BMS - Autoimmune Disease Drugs Business funding
BMS - Autoimmune Disease Drugs Business funding profile: $300M total raised. Latest round: Series A. Backed by Bain Capital, Bain Capital Life Sciences.
Headquarters: New York City, United States
Investors
- Bain Capital
- Bain Capital Life Sciences
Fundraising guides
Browse the company funding database · Browse investors · Fundraising library
